Back to insights

Cost Control to lower CAPEX in Life Sciences

Deerns supports informed investment decisions as cost control in Life Sciences is becoming a strategic design decision rather than just a procurement exercise.

Life sciences projects are facing a level of financial scrutiny that would have been unusual just a few years ago. Rising energy prices, higher material costs, geopolitical uncertainty and increasing competitive pressure are forcing pharmaceutical and biotechnology companies to examine every capital investment more carefully. For many organisations, the challenge is delivering compliant facilities while maintaining a viable business case.

This is where Deerns can help clients make more informed investment decisions. Cost control is becoming a strategic engineering service that can influence project viability from the earliest stages of planning and design.

Why CAPEX Matters More Than Ever

Life sciences facilities are among the most technically complex buildings. Cleanrooms, process utilities, HVAC systems, contamination control measures and validation requirements all contribute to significant capital investment.

At the same time, pharmaceutical manufacturers are operating in a more competitive market environment. Energy costs, fuel costs and raw material prices have increased substantially over recent years.

In this environment, reducing CAPEX is less about cutting costs and more about ensuring every investment delivers operational, regulatory and commercial value.

Looking Beyond Traditional Design Approaches

Many life sciences facilities continue to follow design approaches that have evolved over decades. While these approaches have delivered reliable outcomes, they have often prioritised certainty through oversizing.

Oversizing can provide comfort during validation and regulatory review, but it frequently comes with a cost. These optimisations often require balancing efficiency gains against perceived compliance and operational risk.

4 key considerations are:

  • Higher construction expenditure.
  • Larger mechanical and electrical systems.
  • Increased energy consumption.
  • Greater maintenance requirements.

Today, clients are increasingly asking for cost reduction (both CAPEX and OPEX), but accepting innovative engineering solutions is still a slow process, that will require industry maturity to be scaled up.

Quality by Design as a Cost Control Strategy

One of the most effective ways to control CAPEX is through “Quality by Design”.

Traditionally, projects have prioritised the development of engineering, construction and operational requirements, with quality and validation considerations becoming a primary focus only later in the project lifecycle. The industry is increasingly recognising that this separation can create inefficiencies.

A Quality by Design approach incorporates validation requirements, contamination control strategies and quality objectives directly into the concept design process. This creates stronger alignment between engineering decisions and operational requirements from the beginning.

4 essential benefits include:

  • Reduced risk of costly redesigns
  • Fewer modifications during qualification and validation
  • Better alignment between engineering and quality teams
  • Greater predictability during project delivery

This is where Deerns supports clients by integrating engineering expertise with specialist microbiological and contamination-control knowledge.

Smart Compliance and Sustainability

A second important pillar is “Smart Compliance & Sustainability”.

Historically, compliance and sustainability objectives have sometimes been viewed as separate challenges. In reality, they support one another.

Many sustainability measures generate direct cost benefits. Lower energy consumption reduces operating costs. Reduced water consumption decreases both resource use and utility expenditure. Waste reduction improves environmental performance while simultaneously lowering operational costs.

" The key is achieving these benefits holistically without compromising regulatory compliance.
Cosimo Verteramo Life Science & High Tech Division Director at Deerns

Examples include intelligent environmental control systems, optimised cleanroom strategies, dynamic HVAC operation and advanced monitoring technologies.

Digital technologies are also creating new opportunities. Advanced monitoring systems, IoT-enabled sensors, Digital Twin applications and data-driven control strategies increasingly supported by AI, could provide greater visibility into facility performance.

Learning from Other High-Tech Sectors

Some of the most valuable lessons come from adjacent industries.

Deerns has delivered projects in sectors such as electronics and data centres that face many of the same challenges around controlled environments, energy consumption and operational resilience.

3 examples include:

  • Heat recovery from compressed air systems to preheat water and reduce energy demand.
  • Recovery and reuse of valuable process gases such as helium and argon.
  • Reuse of waste heat from hyperscale data centres to support district heating networks.

While these examples originate outside the pharmaceutical sector, they demonstrate an important principle: waste can often be transformed into value through intelligent engineering.

Overcoming Industry Resistance

Perhaps the greatest challenge is not technical but cultural.

Life sciences companies operate under rigorous regulatory frameworks. Validation by organisations such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA) is essential to market access. Any perceived risk to compliance is understandably approached with caution.

This means innovation must be introduced carefully.

Progress is likely to be incremental, with solutions that deliver measurable benefits while maintaining compliance gaining acceptance more readily than disruptive change.

" Education, pilot projects and industry engagement will be essential in demonstrating that smarter engineering can improve both compliance and cost performance.
Cosimo Verteramo Life Science & High Tech Division Director at Deerns

Engineering Value into Every Investment

The life sciences sector is entering a period where capital efficiency is becoming as important as technical excellence. Rising costs and tighter business cases mean every investment must deliver maximum value.

Cost control is therefore evolving into a strategic engineering discipline. Through Quality by Design, Smart Compliance & Sustainability and an integrated approach spanning engineering, microbiology and contamination control, Deerns helps clients create facilities that are compliant, efficient, resilient and commercially successful.

Related thoughts

Let’s talk


Ester Vlielander

Unit Director Life Sciences, Electronics & Data Centres

Array